Table 3.
Univariate and multivariable analyses for the relationship between LRH1 expression and lymph node metastasis in OCs.
| Variables | No. | Lymph node metastasis | P | OR (95%CI) | P | |
|---|---|---|---|---|---|---|
| Negative | Positive | |||||
| Age (years) | 0.775 | |||||
| ≤52 | 40 | 27 | ||||
| >52 | 41 | 25 | ||||
| Histological type | 0.991 | |||||
| Serous | 56 | 36 | ||||
| Others | 25 | 16 | ||||
| Histologic grade | 0.016 | 2.421 (1.109–5.285) | 0.026 | |||
| G1/G2 | 37 | 13 | ||||
| G3 | 44 | 39 | ||||
| Residual disease (cm) | 0.595 | |||||
| <1 | 61 | 37 | ||||
| ≥1 | 20 | 15 | ||||
| Ascites (ml) | 0.653 | |||||
| <100 | 22 | 16 | ||||
| ≥100 | 59 | 36 | ||||
| Serum CA-125 level (U/ml) | 0.991 | |||||
| ≤35 | 25 | 16 | ||||
| >35 | 56 | 36 | ||||
| LRH1 expression level | 0.011 | 2.451 (1.162–5.173) | 0.019 | |||
| Low | 43 | 16 | ||||
| High | 38 | 36 | ||||
OC, ovarian cancer; HR, hazard ratio; CI, confidence interval.